A clinical study by Nakamura et al. found that serum sRAGE levels in DN patients were negatively correlated with markers of renal tubular damage, such as KIM-1 and NGAL, suggesting that sRAGE may have a protective effect [49]. Here, AGER is linked to liver dysplastic nodule.